Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBITDA Margin (2024 - 2025)

Rallybio's EBITDA Margin history spans 2 years, with the latest figure at 7558.02% for Q3 2025.

  • For Q3 2025, EBITDA Margin rose 1131253.0% year-over-year to 7558.02%; the TTM value through Sep 2025 reached 2243.73%, up 889272.0%, while the annual FY2024 figure was 9620.33%, N/A changed from the prior year.
  • EBITDA Margin for Q3 2025 was 7558.02% at Rallybio, up from 4591.04% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 7558.02% in Q3 2025 and bottomed at 557250.0% in Q4 2024.